28 Apr 2017 --- Lesaffre Human Care, supplier ingredients from yeast and bacteria fermentation for the global human care markets, will be presenting Lynside Vaginactiv, its new range of ingredients dedicated to women’s health at Vitafoods this year. As of now, the range includes two unique and completely natural solutions that have demonstrated efficacy on vaginal health in recent studies, in particular in fighting pathogenic yeast Candida albicans, a prominent cause of vaginal infections.
Vulvovaginal candidiasis is in fact one of the most prevalent causes of vaginal infections in women of reproductive age and is characterized by the disruption of the vaginal microbiota composition. This unbalance favors opportunistic pathogen Candida albicans overgrowth. With over 75% of women worldwide experiencing at least one episode of vulvovaginal candidiasis in their life, 4 to 8% of whom suffering from recurrence (4 or more per year), Lynside Vaginactiv aims to provide natural and innovative solutions to get rid of C. albicans and prevent its recurrence.
The company offers two distinct ingredients for day-to-day support to deliver long term results: Lynside Vaginactiv Oral, a unique probiotic yeast (Saccharomyces cerevisiae CNCM I-3856) designed for oral use; and Pharma Vaginactiv Local, a specific dried yeast (Saccharomyces cerevisiae CNCM I-3856) designed for medical devices for vaginal application and certified Active Pharmaceutical Ingredient (API).
Offering different responses to a common challenge, these two ingredients can be used individually or concomitantly to fight vaginal infections and prevent recurrence.
These two outstanding yeasts recently received attention from the scientific community and notably from Dr Duncan Wilson, research fellow at the University of Aberdeen (UK), who wrote about their positive influence on the course of vaginal candidiasis. In a paper published in Virulence, researchers also discuss how the post-challenge administration of living yeast S. cerevisiae CNCM I-3856 or dried yeast was able to accelerate the clearance of C. albicans in an experimental model of vulvo-vaginal candidiasis. Both were found to induce coaggregation with the pathogen allowing its fast elimination. Lynside Vaginactiv Oral was also able to suppress major virulence factors of C. albicans.
Click to EnlargeLesaffre Human Care will also be showcasing Lynside ProteYn, the first yeast protein on the market, officially launched at HIE last year. Containing all essential amino acids, including branched-chain amino acids, Lynside ProteYn is a complete protein, perfect for people seeking to enhance their protein intake with non-animal protein sources. Lesaffre Human Care yeast proteins are characterized by an excellent chemical score and Protein Digestibility–Corrected Amino Acid Score (PDCASS), respectively above 100% and greater than 1, which is similar to dairy protein and much higher than all plant-based proteins.
Besides offering a complete high-profile aminogram and high digestibility score, Lynside ProteYn ingredients are also packed with micronutrients such as naturally-occurring fibers, B vitamins and minerals such as iron, zinc, calcium, magnesium, phosphorus and potassium. This can prove to be a very valuable asset for people such as vegan, vegetarians of flexitarians, who are at increased risk of vitamin and mineral deficiency.
Building upon the notoriety of nutritional yeasts as well as the company’s 160 years of experience in yeast development, Lesaffre Human Care yeast proteins are designed to resonate with modern consumers who are looking for nutrient-packed food they can trust. Lynside ProteYn is non-GMO, allergen-free (gluten, dairy and soy-free) and free from anti-nutritional factors such as protease inhibitors, phytates, etc. Moreover, Lesaffre Human Care’s yeast protein have been produced without pesticides or antibiotics for growth.
Thanks to a very specific and perfectly mastered manufacturing process, Lynside ProteYn also benefits from having a low environmental impact (low water consumption, reduced carbon footprint, quick turnaround, etc.). It can therefore be considered as a sustainable protein, in comparison to other more resource-intensive and environmentally impactful options.
11 May 2018 –
US researchers examining how to manipulate gut ...
04 May 2018 –
Lonza has reported a “positive” ...
02 May 2018 –
Nexira, a global leader in natural and organic ...
20 Apr 2018 –
Fermentalg, a French supplier of microalgae for ...
09 Apr 2018 –
Novartis has entered into an agreement and plan ...